Showing results (2671-2680 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|October 12, 2012
Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumorsMaja J A de Jonge, Paul Hamberg, Jaap Verweij, et al.
Investigational New Drugs|October 12, 2012
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell linesDavid Davidson, Yunzhe Wang, Raquel Aloyz, et al.
Investigational New Drugs|March 23, 2010
Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancerColin D Weekes, Sujatha Nallapareddy, Michelle A Rudek, et al.
Investigational New Drugs|May 12, 2023
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumorsGerald S Falchook, Jasgit Sachdev, Esteban Rodrigo Imedio, et al.
Investigational New Drugs|May 24, 2014
Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancerChristina A K Kim, Julie Price-Hiller, Quincy S Chu, et al.
Investigational New Drugs|February 28, 2015
3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potencyFahad S Aldawsari, Carlos A Velázquez-Martínez
Investigational New Drugs|March 31, 2015
Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside AAriane Chan, A Jonathan Singh, Peter T Northcote, et al.
Investigational New Drugs|April 8, 2015
The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patientsSatoru Miura, Kyoichi Kaira, Rieko Kaira, et al.
Investigational New Drugs|August 1, 2020
Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy typesMan-Fei Zhao, Gong-Da Liang, Yu-Jie Zhou, et al.
Investigational New Drugs|July 11, 2020
Acute tubulointerstitial nephritis induced by the tyrosine kinase inhibitor vandetanibMelissa Pilco Teran, Ana Merino Ribas, Nadia Martin Alemany, et al.
Pageof 372